US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NETLease Corporate Real Estate ETF

26.79

+0.18100.68%

Post-market: 26.810.0190+0.07%19:30 EDT

Volume:7K

Turnover:199.44K

Market Cap:55.59M

PE:- -

High:26.81

Open:26.81

Low:26.68

Close:26.61

52wk High:28.43

52wk Low:23.56

Shares:2.08M

Float Shares:2.08M

Volume Ratio:0.68

T/O Rate:0.36%

Dividend:1.25

Dividend Rate:4.67%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Agree Realty Corp Expected to Post Earnings of 47 Cents a Share - Earnings Preview

W.P. Carey raises FY26 AFFO view to $5.19-$5.27 from $5.16-$5.26

WP Carey Q2 Revenue Beats Estimates on Higher Leases; AFFO Outlook Raised

GUIDANCE: (WPC) W. P. Carey Expects Full Year 2026 AFFO Range $5.19 - $5.27, vs. FactSet Est of $5.23

MT Newswires Live

WP Carey Q2 Affo USD 305.4 Million

THOMSON REUTERS

WP Carey Q2 EPS USD 0.82

THOMSON REUTERS

WP Carey Outlook FY Affo Per Diluted Share $5.19 – $5.27

THOMSON REUTERS

BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data

South Korea, Brazil Agree to Accelerate Mercosur Trade Deal Talks

MT Newswires Live

Accenture Stock And 2 Dividend Shares Offering Steady Income

Simply Wall St.

VICI Properties Inc Expected to Post Earnings of 71 Cents a Share - Earnings Preview

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

Kelun Pharmaceutical's Subsidiary Kelun-Biotech Gets Approval for Clinical Trial of Novel Dual-Load ADC Drug SKB565

Impact Therapeutics Nominates Preclinical Candidate for GI Cancers

MT Newswires Live

IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Simply Wall St.

BIOKIN's T-Bren (HER2 ADC) Trial Enrolls First Subject in Phase III Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NETL/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NETL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","market":"US","secType":"STK","nameCN":"NETLease Corporate Real Estate ETF","latestPrice":26.791,"timestamp":1787601600000,"preClose":26.61,"halted":0,"volume":7452,"hourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.791,"latestTime":"19:30 EDT","volume":9,"amount":241.119,"timestamp":1787614206571,"change":0.019,"changeRate":0.000709,"amplitude":0},"delay":0,"changeRate":0.006801954152574256,"floatShares":2075000,"shares":2075000,"eps":0,"marketStatus":"Not Yet Opened","change":0.181,"latestTime":"08-24 16:00:00 EDT","open":26.8094,"high":26.81,"low":26.6796,"amount":199439.768808,"amplitude":0.0049,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":26.61,"sharesOutstanding":1775000,"nav":26.54,"aum":55070500,"dividendRate":0.046684,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.791,"latestTime":"19:30 EDT","volume":9,"amount":241.119,"timestamp":1787614206571,"change":0.019,"changeRate":0.000709,"amplitude":0},"volumeRatio":0.683971,"impliedVol":0.0633,"impliedVolPercentile":0.048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","floatShares":2075000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.683971,"shares":2075000,"dividePrice":1.2507,"high":26.81,"amplitude":0.0049,"preClose":26.61,"low":26.6796,"week52Low":23.56,"pbRate":"--","week52High":28.4299,"institutionHeld":0,"latestPrice":26.791,"eps":0,"divideRate":0.046684,"volume":7452,"delay":0,"ttmEps":0,"open":26.8094,"prevYearClose":23.727,"prevWeekClose":26.61,"prevMonthClose":27.14,"prevQuarterClose":26.7001,"fiveDayClose":26.48,"twentyDayClose":27.9307,"sixtyDayClose":26.3675},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NETL\",params:#limit:5,,,undefined,":[{"date":"2026-07-29","symbol":"NETL","amount":0.105,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-29","defaultRemindTime":1785331800000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-29","currency":"USD","dateTimestamp":1785297600000,"payDate":"2026-07-31"},{"date":"2026-06-26","symbol":"NETL","amount":0.105,"announcedDate":"2026-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-26","defaultRemindTime":1782480600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-26","currency":"USD","dateTimestamp":1782446400000,"payDate":"2026-06-30"},{"date":"2026-05-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-05-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-27","defaultRemindTime":1779888600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-27","currency":"USD","dateTimestamp":1779854400000,"payDate":"2026-05-29"},{"date":"2026-04-28","symbol":"NETL","amount":0.105,"announcedDate":"2026-04-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-04-30"},{"date":"2026-03-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-27","defaultRemindTime":1774618200000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-27","currency":"USD","dateTimestamp":1774584000000,"payDate":"2026-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NETL\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-02","value":0.031935,"currency":"USD"},{"executeDate":"2020-03-17","recordDate":"2020-03-18","paymentDate":"2020-03-19","value":0.0097783,"currency":"USD"},{"executeDate":"2020-03-31","recordDate":"2020-04-01","paymentDate":"2020-04-02","value":0.1912399,"currency":"USD"},{"executeDate":"2020-06-26","recordDate":"2020-06-29","paymentDate":"2020-06-30","value":0.2782635,"currency":"USD"},{"executeDate":"2020-09-15","recordDate":"2020-09-16","paymentDate":"2020-09-30","value":0.2792338,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NETL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NETL\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655370838","title":"Agree Realty Corp Expected to Post Earnings of 47 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655370838","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655370838?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:32","pubTimestamp":1785270726,"startTime":"0","endTime":"0","summary":"Agree Realty Corp <ADC.N> expected to post earnings of47cents a share - Earnings PreviewAgree Realty CorpADC.N,ADCis expected to  show a rise in quarterly revenue when it reports  results on July 30 f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL8N43U3AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655272880","title":"W.P. Carey raises FY26 AFFO view to $5.19-$5.27 from $5.16-$5.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2655272880","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655272880?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:21","pubTimestamp":1785270101,"startTime":"0","endTime":"0","summary":"Consensus is for FY26 FFO $5.28. Reaffirms FY26 General and administrative expenses view $1.03M-$106M Published first on TheFly – the ultimate sour...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/w-p-carey-raises-fy26-affo-view-to-5-19-5-27-from-5-16-5-26-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/w-p-carey-raises-fy26-affo-view-to-5-19-5-27-from-5-16-5-26-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDS","NETL","BK4160","WPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655809558","title":"WP Carey Q2 Revenue Beats Estimates on Higher Leases; AFFO Outlook Raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2655809558","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655809558?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:16","pubTimestamp":1785269778,"startTime":"0","endTime":"0","summary":"WP Carey Q2 revenue beats estimates on higher leases; AFFO outlook raisedOverviewU.S. net lease REIT's Q2 revenue rose 7% yr/yr, beating analyst expectationsQ2 AFFO per share rose 4.7% yr/yr; full-yea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL1N43U186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4215","BRX","BK4228","INDS","BK4160","TXXS","SUI","NETL","WPC","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655788086","title":"GUIDANCE: (WPC) W. P. Carey Expects Full Year 2026 AFFO Range $5.19 - $5.27, vs. FactSet Est of $5.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2655788086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655788086?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:08","pubTimestamp":1785269280,"startTime":"0","endTime":"0","summary":"GUIDANCE: (WPC) W. P. Carey Expects Full Year 2026 AFFO Range $5.19 - $5.27, vs. FactSet Est of $5.23","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WPC","NETL","INDS","BK4160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887231","title":"WP Carey Q2 Affo USD 305.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887231?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX6HMQ98:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NETL","INDS","WPC","BK4160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887178","title":"WP Carey Q2 EPS USD 0.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887178?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX6HMQ98:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WPC","INDS","BK4160","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655838454","title":"WP Carey Outlook FY Affo Per Diluted Share $5.19 – $5.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2655838454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655838454?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX6HMQ98:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDS","WPC","NETL","BK4160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654900071","title":"BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2654900071","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654900071?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:15","pubTimestamp":1785244500,"startTime":"0","endTime":"0","summary":"Revised agreement provides BiomX with additional flexibility to support Zorronet while further aligning BiomX and Water IO around Zorronet's long-term successNETANYA, Israel, July  28, 2026  (GLOBE NE","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334373/0/en/BiomX-And-Water-IO-Agree-To-Updated-Zorronet-Acquisition-Terms.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654000439","title":"Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654000439","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654000439?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:00","pubTimestamp":1785240000,"startTime":"0","endTime":"0","summary":"Company expects to initiate enrollment in TEMPO-1 in September 2026OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the 2L setting in the U.S. with approximately 14,000 patients","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334206/0/en/Corbus-Pharmaceuticals-Announces-FDA-Clearance-to-Initiate-TEMPO-1-Registrational-Study-of-CRB-701-in-Patients-with-2L-Oropharyngeal-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4211","ORR","BK4588","BK4585","BK4139","CRBP","BK4080","BK4231","LABU","PFS","NETL","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654781960","title":"Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2654781960","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654781960?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:37","pubTimestamp":1785213461,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. Class H ( ($HK:2157) ) has provided an announcement. Lepu Biopharma reported that its Claudin 18.2-targeting antibody-drug ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lepu-biopharmas-claudin-18-2-adc-cmg901-delivers-positive-global-phase-iii-gastric-cancer-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lepu-biopharmas-claudin-18-2-adc-cmg901-delivers-positive-global-phase-iii-gastric-cancer-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","BK4080","ADC","NETL","III","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654022492","title":"South Korea, Brazil Agree to Accelerate Mercosur Trade Deal Talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2654022492","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654022492?lang=en_us&edition=fundamental","pubTime":"2026-07-28 10:19","pubTimestamp":1785205148,"startTime":"0","endTime":"0","summary":"South Korean President Lee Jae Myung and Brazilian President Luiz Inácio Lula da Silva agreed on Monday to accelerate negotiations for a long-delayed free trade agreement between South Korea and the Mercosur bloc.During their summit in Brasília, the two leaders declared 2026 as the inaugural year of a new Korea-Brazil Strategic Partnership, establishing a high-level committee to deepen cooperation in trade, defense, aerospace, and critical minerals, according to a transcript of the summit shared on YouTube by Yonhap News.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NETL","BK4231","ADC","EWZS","BK4080","AAQC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654020801","title":"Accenture Stock And 2 Dividend Shares Offering Steady Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2654020801","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654020801?lang=en_us&edition=fundamental","pubTime":"2026-07-28 10:18","pubTimestamp":1785205122,"startTime":"0","endTime":"0","summary":"With inflation, energy prices and central banks all pulling on your portfolio at once, steady dividend income can feel more valuable than ever. That is where Dividend Powerhouses with 5%+ yields and a track record of well covered, growing and stable payouts come in. This screener focuses on companies that put cash returns to shareholders at the centre of their story. This can help balance choppy markets and mixed growth signals across regions. In this article, you will see 3 of the strongest...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/accenture-stock-and-2-dividend-shares-offering-steady-income","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/accenture-stock-and-2-dividend-shares-offering-steady-income","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0330918003.SGD","VOTE","BK4585","PMDE","LU1223083913.SGD","LU0553294199.USD","AU","AFK","LU0303823156.USD","LU0265550946.USD","ACN","LU0323239441.USD","LU0788108826.HKD","GDMN","LU0289739343.SGD","LU1823568750.SGD","NETL","LU1032466523.USD","LU1989772840.SGD","GDX","LU0149725797.USD","IE0004445015.USD","LU0661504455.SGD","SG9999014914.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","BK4588","LU1116320901.HKD","LU1868838027.USD","DECU","LU1046421795.USD","VIG","LU2133065610.SGD","BK4533","LU1235294995.USD","LU0289960550.SGD","GQRE","LU0342679015.USD","LU1003077747.HKD","LU2247934214.USD","VICI","AUMI","BK4017","LU1102505762.USD","SG9999014880.SGD","TSRS","LU0323240290.USD","AUAU","GLDN","LU0303821028.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654231340","title":"VICI Properties Inc Expected to Post Earnings of 71 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2654231340","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654231340?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:56","pubTimestamp":1785185765,"startTime":"0","endTime":"0","summary":"VICI Properties Inc <VICI.N> expected to post earnings of71cents a share - Earnings PreviewVICI Properties IncVICI.N,VICI.Kis expected to  show a rise in quarterly revenue when it reports  results on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL8N43T21S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","VICI","TSRS","BK4234","BK4561","BK4084","BK4588","BK4585","GQRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047585","title":"VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047585","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047585?lang=en_us&edition=fundamental","pubTime":"2026-07-28 02:30","pubTimestamp":1785177027,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, July 27th, 2026, FinanceWire VERAXA Biotech (NASDAQ:VRXA) announced the advancement of its bispecific antibody-d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-bispecific-adc-program-under-omniab-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-bispecific-adc-program-under-omniab-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQY","FTEC","TQQY","BK4585","QQQM","BK4231",".IXIC","ONEQ","NVIW.SI","QQQJ","QQQ","SQQQ","NETL","QQQE","ADC","QLD","GPIQ","IYW","BK4581","BK4080","NQmain","VRXA","QQQA","XBI","QDTE","BK4588","MNQmain","NDX","QYLG","TECS","BK4139","TQQQ","PSQ","QID","JEPQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654049878","title":"Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2654049878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654049878?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:55","pubTimestamp":1785164125,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Boris Peaker has maintained their bullish stance on ANL stock, giving a Buy rating on July 16. Boris Peaker has given his Buy ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/adlai-nortye-initiated-with-buy-on-differentiated-ras-targeting-pipeline-adc-strategy-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/adlai-nortye-initiated-with-buy-on-differentiated-ras-targeting-pipeline-adc-strategy-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ199S13.USD","ADC","ALN","BK4139","BK4231","ANL","BK4080","LU2133065610.SGD","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142348091","title":"Kelun Pharmaceutical's Subsidiary Kelun-Biotech Gets Approval for Clinical Trial of Novel Dual-Load ADC Drug SKB565","url":"https://stock-news.laohu8.com/highlight/detail?id=1142348091","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142348091?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:20","pubTimestamp":1785162017,"startTime":"0","endTime":"0","summary":"Sichuan Kelun Pharmaceutical Co.,Ltd. (SZ: 002422) has announced that its controlling subsidiary, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., received a clinical trial approval notice from the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","PSYK","ADC","LU2148510915.USD","BK0239","MDTX","BK4231","IBBQ","BMED","LU1064130708.USD","BK0060","002422","LU1979443071.USD","IND","LU1064131003.USD","NETL","LU1934453819.USD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654092639","title":"Impact Therapeutics Nominates Preclinical Candidate for GI Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2654092639","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654092639?lang=en_us&edition=fundamental","pubTime":"2026-07-27 14:28","pubTimestamp":1785133700,"startTime":"0","endTime":"0","summary":"Impact Therapeutics  nominated IMP3201, a CEACAM5-targeted dual-payload antibody-drug conjugate , as a preclinical candidate.IMP3201 is the first preclinical candidate developed using its proprietary dual-payload ADC platform, according to a Monday Hong Kong bourse filing. It is being developed to treat gastrointestinal cancers, including colorectal, pancreatic, gastric and esophageal squamous cell carcinoma.Shares of the company fell over 6% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","07630","BK4231","BK4539","BK7095","BK1161","ADC","BK4139","NETL","BK4007","ADC.AU","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060520","title":"IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060520","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060520?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:37","pubTimestamp":1785109040,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. Class H ( ($HK:7630) ) has shared an announcement. IMPACT Therapeutics has nominated IMP3201 as a pre-clinical candidate,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/impact-therapeutics-unveils-first-dual-payload-adc-preclinical-candidate-imp3201?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/impact-therapeutics-unveils-first-dual-payload-adc-preclinical-candidate-imp3201?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","BK4139","BK4007","BK4080","LENZ","NETL","ADC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654061156","title":"Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?","url":"https://stock-news.laohu8.com/highlight/detail?id=2654061156","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654061156?lang=en_us&edition=fundamental","pubTime":"2026-07-26 23:34","pubTimestamp":1785080062,"startTime":"0","endTime":"0","summary":"Agree Realty Corporation recently declared a monthly cash dividend of US$0.267 per common share and US$0.08854 per 4.25% Series A preferred depositary share, with both payouts scheduled for August 2026 to shareholders of record in late July 2026.\nThe common dividend represents a 4.3% annualized increase from the third quarter of 2025 rate, underscoring the REIT’s emphasis on returning cash to shareholders across both its common and preferred capital structure.\nNext, we’ll examine how this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/does-agree-realtys-higher-2026-dividend-payout-reveal-a-deep","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/does-agree-realtys-higher-2026-dividend-payout-reveal-a-deep","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NETL","BK4588","BK4585","BK4080","ADC","VIG","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115050037","title":"BIOKIN's T-Bren (HER2 ADC) Trial Enrolls First Subject in Phase III Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1115050037","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115050037?lang=en_us&edition=fundamental","pubTime":"2026-07-26 15:54","pubTimestamp":1785052454,"startTime":"0","endTime":"0","summary":"BIOKIN (SH: 688506) has announced that the first patient has been enrolled in a Phase III randomized controlled clinical trial for its innovative biologic drug, T-Bren (HER2 ADC), developed in-house....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91194","PSYK","NETL","02615","IBBJ","688506","ADC","BMED","BK4080","BK4231","IBBQ","BK0239","MDTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}